@nytimes
The New York Times
9 days ago
In new setbacks for the AstraZeneca vaccine, Britain said it would offer alternatives to people under 30, while the EU regulator said it had found a "possible link" to rare blood clots. https://t.co/i9SBts36Dk
19
75
171

Replies

@daisy11298
Daisy
9 days ago
@nytimes Why under 30? They're getting blood clots? That's weird.
0
0
1
@Shkwid
Twill
9 days ago
@nytimes Or perhaps treat those in danger? https://t.co/pgICA55ptQ
Tweet media one
0
1
4
@docsamu78
Christian
9 days ago
@nytimes @patriciajaniot `cos too late, and britain may choose AS
0
0
1
@willysxml
William Large
9 days ago
@nytimes So people over 30 don't matter anymore. Are they just collateral damage? This approach is just simply inhumane and prejudiced.
0
0
2
@igorsmessage
Igor
8 days ago
@nytimes I am not sure I am confident with this age discrimination. Seems like the logic is first come first serve so not to halt the 💉 rollout.
0
0
0